Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;120(4):440-442.
doi: 10.1007/s00347-023-01816-6. Epub 2023 Feb 17.

[Revision of the PRESERFLO® MicroShunt with ologen and mitomycin C]

[Article in German]
Jan Niklas Lüke  1 , Philip Enders  2 , Alexandra Lappa  2 , Thomas S Dietlein  2
Affiliations
Review

[Revision of the PRESERFLO® MicroShunt with ologen and mitomycin C]

[Article in German]
Jan Niklas Lüke et al. Ophthalmologie. 2023 Apr.

Abstract
in English, German

Bleb failure after implantation of filtering stents (e.g. Preserflo Stent) is a frequent challenge in glaucoma surgery that has occurred in recent years. In the following, a technique for open bleb revision with mitomycin C (0.2 mg/ml) and ologen implantation is presented, which is intended to re-establish the filtration volume lost due to fibrosis and a long-term preservation.

Filterkissenversagen nach Implantation von filtrierenden Stents (z. B. Preserflo Stent) stellen eine über die letzten Jahre entstandene häufige Herausforderung in der Glaukomchirurgie dar. Im Folgenden wird hierzu eine Technik zur offenen Filterkissenrevision mit Mitomycin C (0,2 mg/ml) und Ologen-Implantation dargestellt, deren Ziel es ist, durch Fibrose verloren gegangenes Filtrationsvolumen zu reetablieren und längerfristig zu erhalten.

Keywords: Bleb; Filtering surgery; Glaucoma; Stent; Trabeculectomy.

PubMed Disclaimer

References

Literatur

    1. Fili S, Seddig S, Kohlhaas M (2019) Langzeitergebnisse nach Trabekulektomie kombiniert mit Mitomycin C und einem Ologen-Implantat. Klin Monatsbl Augenheilkd 236:1107–1114. https://doi.org/10.1055/s-0044-101461 - DOI - PubMed
    1. Kornmann HL, Fellman RL, Smith OU et al (2021) Outcomes of bleb revision with ologen following filtering glaucoma surgery. Eur J Ophthalmol. https://doi.org/10.1177/11206721211053503 - DOI - PubMed
    1. Lavia C, Dallorto L, Maule M et al (2017) Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS ONE 12:e183142. https://doi.org/10.1371/journal.pone.0183142 - DOI - PubMed - PMC
    1. Rosentreter A, Mellein AC, Konen WW, Dietlein TS (2010) Capsule excision and OlogenTM implantation for revision after glaucoma drainage device surgery. Graefes Arch Clin Exp Ophthalmol 248:1319–1324. https://doi.org/10.1007/s00417-010-1385-y - DOI - PubMed
    1. Rosentreter A, Schild AM, Jordan JF et al (2010) A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma. Eye 24:1449–1457. https://doi.org/10.1038/eye.2010.106 - DOI - PubMed

Substances

LinkOut - more resources